Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
A 6-month controlled trial in diabetics with ischemic heart disease showed that empagliflozin attenuated both inflammation and systemic oxidative stress, resulting in clinically significant cardiovascular benefits (Gohari et al., 2022)
In South Africa, these medicines remain largely inaccessible given their high costs, despite the large public health need for effective treatments for diabetes and obesity
The compound called retatrutide is technically a "GLP-1/GIP/glucagon triple agonist" or "triple receptor agonist." The "GLP-3" naming is a marketing-friendly shorthand that's emerged because it follows the intuitive progression from "GLP-1" to "GLP-3" implying a third generation of metabolic peptide research
Pregnancy and lactation represent relative contraindications given absence of human safety data in these populations despite reassuring preclinical reproductive toxicology studies
A83536 Goat polyclonal antibody to GLP-1R for ELISA, WB and IHC
Gastrointestinal Irritation In some cases, digestive changes caused by medication may lead to irritation in the gastrointestinal tract
US$ 28.33
US$ 21.80
US$ 23.49
US$ 26.71
US$ 25.23
US$ 28.17
US$ 24.32
